πŸ‡ΊπŸ‡Έ FDA
Patent

US 8907053

Immunosuppression modulating compounds

granted A61KA61K38/00A61P

Quick answer

US patent 8907053 (Immunosuppression modulating compounds) held by Aurigene Discovery Technologies Limited expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aurigene Discovery Technologies Limited
Grant date
Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K38/00, A61P, A61P1/04, A61P1/18